TECH (STOCKS)
Bio-Techne Corp.
$56.170000
+2.170000 (+4.02%)
Prev close: $54.000000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kim Kelderman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8,792.92M
- Employees
- 3,100
- P/E (TTM)
- 77.56
- P/B (TTM)
- 4.05
- Dividend Yield
- 59.26%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
9
Buy
5
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q3)
|
$0.53 | $0.55 | -0.0183 | -3.34% |
|
Dec 2025 (Q2)
|
$0.46 | $0.44 | +0.0175 | +3.95% |
|
Sep 2025 (Q1)
|
$0.42 | $0.43 | -0.0087 | -2.03% |
|
Jun 2025 (Q4)
|
$0.53 | $0.51 | +0.0211 | +4.15% |
Financial Statements
| Revenues | $1.21B |
| Benefits Costs and Expenses | $1.06B |
| Cost Of Revenue | $424.32M |
| Costs And Expenses | $1.06B |
| Gross Profit | $786.49M |
| Nonoperating Income/Loss | -$6.61M |
| Operating Expenses | $632.74M |
| Selling, General, and Administrative Expenses | $535.88M |
| Other Operating Expenses | $96.85M |
| Operating Income/Loss | $153.75M |
| Income/Loss Before Equity Method Investments | $146.37M |
| Income/Loss From Continuing Operations After Tax | $109.56M |
| Income/Loss From Continuing Operations Before Tax | $147.14M |
| Income/Loss From Equity Method Investments | $772.00K |
| Income Tax Expense/Benefit | $37.58M |
| Net Income/Loss | $109.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $109.56M |
| Net Income/Loss Available To Common Stockholders, Basic | $109.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $128.00K |
| Preferred Stock Dividends And Other Adjustments | $64.00K |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | $64.00K |
| Basic Earnings Per Share | $0.71 |
| Diluted Earnings Per Share | $0.70 |
| Basic Average Shares | 155,297,000 |
| Diluted Average Shares | 155,998,000 |
| Assets | $2.55B |
| Current Assets | $688.05M |
| Inventory | $201.18M |
| Other Current Assets | $486.88M |
| Noncurrent Assets | $1.86B |
| Fixed Assets | $232.99M |
| Intangible Assets | $319.07M |
| Other Non-current Assets | $1.31B |
| Liabilities | $465.30M |
| Current Liabilities | $153.28M |
| Accounts Payable | $23.49M |
| Wages | $54.43M |
| Other Current Liabilities | $75.36M |
| Noncurrent Liabilities | $312.02M |
| Equity | $2.09B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.09B |
| Liabilities And Equity | $2.55B |
| Net Cash Flow From Operating Activities | $294.86M |
| Net Cash Flow From Operating Activities, Continuing | $294.86M |
| Net Cash Flow From Investing Activities | -$10.73M |
| Net Cash Flow From Investing Activities, Continuing | -$10.73M |
| Net Cash Flow From Financing Activities | -$226.36M |
| Net Cash Flow From Financing Activities, Continuing | -$226.36M |
| Net Cash Flow | $57.77M |
| Net Cash Flow, Continuing | $57.77M |
| Comprehensive Income/Loss | $124.76M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $124.76M |
| Other Comprehensive Income/Loss | $15.20M |